{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:16:56Z","timestamp":1793866616323,"version":"4.6.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"am","delay-in-days":393,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004571","name":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006251","name":"Universit\u00e9 de Bordeaux","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006251","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009242","name":"DGOS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","award":["13\u2013077"],"award-info":[{"award-number":["13\u2013077"]}],"id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Hygiene and Environmental Health"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ijheh.2023.114264","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T13:37:36Z","timestamp":1695908256000},"page":"114264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Factors associated with internal contamination of nurses by antineoplastic drugs based on biomonitoring data from a previous study"],"prefix":"10.1016","volume":"254","author":[{"given":"Antoine","family":"Villa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6441-4900","authenticated-orcid":false,"given":"Arna","family":"Geshkovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauthier","family":"Bellagamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4346-8346","authenticated-orcid":false,"given":"Mathieu","family":"Molimard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Verdun-Esquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pascale","family":"Lehucher-Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4140-1639","authenticated-orcid":false,"given":"Mireille","family":"Canal-Raffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijheh.2023.114264_bib1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1080\/15459624.2015.1029610","article-title":"Adherence to precautionary guidelines for compounding antineoplastic drugs: a survey of nurses and pharmacy practitioners","volume":"12","author":"Boiano","year":"2015","journal-title":"J. Occup. Environ. Hyg."},{"key":"10.1016\/j.ijheh.2023.114264_bib2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/15459624.2014.916809","article-title":"Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs","volume":"11","author":"Boiano","year":"2014","journal-title":"J. Occup. Environ. Hyg."},{"key":"10.1016\/j.ijheh.2023.114264_bib3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/jech-2019-212225","article-title":"Current challenges in population health intervention research","volume":"73","author":"Cambon","year":"2019","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.ijheh.2023.114264_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2016.10.021","article-title":"Highly sensitive LC-MS\/MS methods for urinary biological monitoring of occupational exposure to cyclophosphamide, ifosfamide, and methotrexate antineoplastic drugs and routine application","author":"Canal-Raffin","year":"2016","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ijheh.2023.114264_bib5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/JOM.0b013e3181f72b63","article-title":"Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers","volume":"52","author":"Connor","year":"2010","journal-title":"J. Occup. Environ. Med."},{"key":"10.1016\/j.ijheh.2023.114264_bib6","first-page":"354","article-title":"Preventing occupational exposures to antineoplastic drugs in health care settings","volume":"56","author":"Connor","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijheh.2023.114264_bib7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/15459624.2017.1285496","article-title":"Effects of organizational safety practices and perceived safety climate on PPE usage, engineering controls, and adverse events involving liquid antineoplastic drugs among nurses","volume":"14","author":"DeJoy","year":"2017","journal-title":"J. Occup. Environ. Hyg."},{"key":"10.1016\/j.ijheh.2023.114264_bib8","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1039\/C8AN00479J","article-title":"Biomonitoring of occupational exposure to 5-FU by assaying \u03b1-fluoro-\u03b2-alanine in urine with a highly sensitive UHPLC-MS\/MS method","volume":"143","author":"Dhersin","year":"2018","journal-title":"Analyst"},{"key":"10.1016\/j.ijheh.2023.114264_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1191\/1078155205jp155oa","article-title":"Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature","volume":"11","author":"Dranitsaris","year":"2005","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.ijheh.2023.114264_bib10","first-page":"107","article-title":"Mise en place d\u2018un syst\u00e8me d\u2018\u00e9valuation des manipulateurs dans une unit\u00e9 de reconstitution de cytotoxiques","volume":"22","author":"Favier","year":"2003","journal-title":"J. Pharm. Clin."},{"key":"10.1016\/j.ijheh.2023.114264_bib11","series-title":"Content and Format of Labeling for Human Prescription Drug and Biological Products ; Requirements for Pregnancy and Lactation Labeling","author":"Fda","year":"2008"},{"key":"10.1016\/j.ijheh.2023.114264_bib12","first-page":"231","article-title":"A pooled analysis to study trends in exposure to antineoplastic drugs among nurses","volume":"51","author":"Fransman","year":"2007","journal-title":"Ann. Occup. Hyg."},{"key":"10.1016\/j.ijheh.2023.114264_bib13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00420-004-0595-1","article-title":"Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities","volume":"78","author":"Fransman","year":"2005","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"10.1016\/j.ijheh.2023.114264_bib14","first-page":"237","article-title":"Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pilot study","volume":"48","author":"Fransman","year":"2004","journal-title":"Ann. Occup. Hyg."},{"key":"10.1016\/j.ijheh.2023.114264_bib15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00420-007-0211-2","article-title":"Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients","volume":"81","author":"Hedmer","year":"2008","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"10.1016\/j.ijheh.2023.114264_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0140-6736(84)92111-1","article-title":"Occupational exposure to cyclophosphamide","volume":"1","author":"Hirst","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ijheh.2023.114264_bib17","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00420-015-1026-1","article-title":"Antineoplastic drug contamination in the urine of Canadian healthcare workers","volume":"88","author":"Hon","year":"2015","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"10.1016\/j.ijheh.2023.114264_bib18","series-title":"Pharmaceuticals","year":"2012"},{"key":"10.1016\/j.ijheh.2023.114264_bib19","series-title":"Some Antiviral and Antineoplastic Drugs, and Other Pharmaceutical Agents","year":"2000"},{"key":"10.1016\/j.ijheh.2023.114264_bib20","series-title":"Overall Evaluations of Carcinogenicity: an Updating of IARC Monographs Volumes 1\u201342, IARC","year":"1987"},{"key":"10.1016\/j.ijheh.2023.114264_bib21","series-title":"Some Antineoplastic and Immunosuppressive Agents","year":"1981"},{"key":"10.1016\/j.ijheh.2023.114264_bib22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/annweh\/wxab013","article-title":"Spatial and temporal variability in antineoplastic drug surface contamination in cancer care centers in alberta and Minnesota","volume":"65","author":"Jeronimo","year":"2021","journal-title":"Ann Work Expo Health"},{"key":"10.1016\/j.ijheh.2023.114264_bib23","first-page":"374","article-title":"Environmental and biological monitoring of platinum-containing drugs in two hospital pharmacies using positive air pressure isolators","volume":"57","author":"Kopp","year":"2013","journal-title":"Ann. Occup. Hyg."},{"key":"10.1016\/j.ijheh.2023.114264_bib24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0003-4878(00)00050-8","article-title":"Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys","volume":"44","author":"Kromhout","year":"2000","journal-title":"Ann. Occup. Hyg."},{"key":"10.1016\/j.ijheh.2023.114264_bib25","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00420-021-01731-w","article-title":"Occupational exposure to antineoplastic drugs: what about hospital sanitation personnel?","volume":"94","author":"Labr\u00e8che","year":"2021","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"10.1016\/j.ijheh.2023.114264_bib26","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/ijc.29058","article-title":"Handling chemotherapy drugs-Do medical gloves really protect?","volume":"137","author":"Landeck","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijheh.2023.114264_bib27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajog.2011.12.030","article-title":"Occupational exposures among nurses and risk of spontaneous abortion","volume":"206","author":"Lawson","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ijheh.2023.114264_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/00039896.1996.9936030","article-title":"Exposure of oncologic nurses to methotrexate in the treatment of osteosarcoma","volume":"51","author":"Mader","year":"1996","journal-title":"Arch. Environ. Health"},{"key":"10.1016\/j.ijheh.2023.114264_bib29","first-page":"657","article-title":"Exposure to antineoplastic drugs outside the hospital environment","volume":"50","author":"Meijster","year":"2006","journal-title":"Ann. Occup. Hyg."},{"key":"10.1016\/j.ijheh.2023.114264_bib30","article-title":"Cyclophosphamide exposure via sweat of patients receiving CHOP therapy","author":"Miyazawa","year":"2022","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.ijheh.2023.114264_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.annepidem.2020.09.003","article-title":"Prepregnancy handling of antineoplastic drugs and risk of miscarriage in female nurses","volume":"53","author":"Nassan","year":"2021","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.ijheh.2023.114264_bib32","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ajim.23015","article-title":"Administration of antineoplastic drugs and fecundity in female nurses","volume":"62","author":"Nassan","year":"2019","journal-title":"Am. J. Ind. Med."},{"issue":"13","key":"10.1016\/j.ijheh.2023.114264_bib33","first-page":"252","article-title":"Soignants et m\u00e9dicaments cytotoxiques. Place de la biom\u00e9trologie dans la ma\u00eetrise des risques dans le temps","volume":"12","author":"Ndaw","year":"2018","journal-title":"Bulletin Epid\u00e9miologique Hebdomadaire"},{"key":"10.1016\/j.ijheh.2023.114264_bib34","series-title":"NIOSH Draft List of Hazardous Drugs in Healthcare Settings, 2020","year":"2020"},{"key":"10.1016\/j.ijheh.2023.114264_bib35","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1039\/c0em00660b","article-title":"Utilization of the solid sorbent media in monitoring of airborne cyclophosphamide concentrations and the implications for occupational hygiene","volume":"13","author":"Odraska","year":"2011","journal-title":"J. Environ. Monit."},{"key":"10.1016\/j.ijheh.2023.114264_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00420-002-0383-8","article-title":"Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations","volume":"76","author":"Pethran","year":"2003","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"10.1016\/j.ijheh.2023.114264_bib37","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1188\/11.ONF.718-726","article-title":"Nurses\u2019 use of hazardous drug-handling precautions and awareness of national safety guidelines","volume":"38","author":"Polovich","year":"2011","journal-title":"Oncol. Nurs. Forum"},{"key":"10.1016\/j.ijheh.2023.114264_bib38","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4212\/cjhp.v69i5.1592","article-title":"Surveillance urinaire des professionnels de la sant\u00e9 expos\u00e9s aux antin\u00e9oplasiques dans le cadre de leur travail: revue de la litt\u00e9rature de 2010 \u00e0 2015","volume":"69","author":"Poupeau","year":"2016","journal-title":"Can. J. Hosp. Pharm."},{"key":"10.1016\/j.ijheh.2023.114264_bib39","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1089\/jwh.2009.1876","article-title":"Occupational exposures and adverse pregnancy outcomes among nurses: a systematic review and meta-analysis","volume":"19","author":"Quansah","year":"2010","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.ijheh.2023.114264_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1472-6955-9-15","article-title":"Cancer incidence and adverse pregnancy outcome in registered nurses potentially exposed to antineoplastic drugs","volume":"9","author":"Ratner","year":"2010","journal-title":"BMC Nurs."},{"key":"10.1016\/j.ijheh.2023.114264_bib41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.mrrev.2017.08.002","article-title":"Meta-analysis of chromosomal aberrations as a biomarker of exposure in healthcare workers occupationally exposed to antineoplastic drugs","volume":"781","author":"Roussel","year":"2019","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ijheh.2023.114264_bib42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00381477","article-title":"Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers","volume":"64","author":"Sessink","year":"1992","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"10.1016\/j.ijheh.2023.114264_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/00039896.1994.9940377","article-title":"Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route?","volume":"49","author":"Sessink","year":"1994","journal-title":"Arch. Environ. Health"},{"key":"10.1016\/j.ijheh.2023.114264_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1078155214522840","article-title":"Environmental contamination, product contamination and workers exposure using a robotic system for antineoplastic drug preparation","volume":"21","author":"Sessink","year":"2015","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.ijheh.2023.114264_bib45","first-page":"855","article-title":"Leukaemia and reproductive outcome among nurses handling antineoplastic drugs","volume":"49","author":"Skov","year":"1992","journal-title":"Br. J. Ind. Med."},{"key":"10.1016\/j.ijheh.2023.114264_bib46","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.jchromb.2010.04.030","article-title":"An analysis to study trends in occupational exposure to antineoplastic drugs among health care workers","volume":"878","author":"Sottani","year":"2010","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ijheh.2023.114264_bib47","article-title":"Duration of sweat cyclophosphamide excretion in patients undergoing a conditioning regimen of high-dose cyclophosphamide for hematopoietic stem-cell transplantation","volume":"10781552221077036","author":"Tanigawa","year":"2022","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.ijheh.2023.114264_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033040","article-title":"Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study","volume":"9","author":"Villa","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijheh.2023.114264_bib49","doi-asserted-by":"crossref","DOI":"10.1007\/s00420-021-01706-x","article-title":"Nurses' internal contamination by antineoplastic drugs in hospital centers: a cross-sectional descriptive study","author":"Villa","year":"2021","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"10.1016\/j.ijheh.2023.114264_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122305","article-title":"A highly sensitive UHPLC-MS\/MS method for urine biological monitoring of occupational exposure to anthracycline antineoplastic drugs and routine application","volume":"1156","author":"Villa","year":"2020","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ijheh.2023.114264_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123411","article-title":"Urine biomonitoring of occupational exposure to methotrexate using a highly sensitive UHPLC-MS\/MS method in MRM3 mode","volume":"1209","author":"Villa","year":"2022","journal-title":"J. Chromatogr., B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ijheh.2023.114264_bib52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/mutage\/geq102","article-title":"Assessment of primary, oxidative and excision repaired DNA damage in hospital personnel handling antineoplastic drugs","volume":"26","author":"Villarini","year":"2011","journal-title":"Mutagenesis"},{"key":"10.1016\/j.ijheh.2023.114264_bib53","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mrrev.2016.05.001","article-title":"Occupational exposure to cytostatic\/antineoplastic drugs and cytogenetic damage measured using the lymphocyte cytokinesis-block micronucleus assay: a systematic review of the literature and meta-analysis","volume":"770","author":"Villarini","year":"2016","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ijheh.2023.114264_bib54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/10773525.2015.1123380","article-title":"Applicability of the comet assay in evaluation of DNA damage in healthcare providers' working with antineoplastic drugs: a systematic review and meta-analysis","volume":"22","author":"Zare Sakhvidi","year":"2016","journal-title":"Int. J. Occup. Environ. Health"},{"key":"10.1016\/j.ijheh.2023.114264_bib55","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ajim.22553","article-title":"Evaluation of adverse health risks associated with antineoplastic drug exposure in nurses at two Chinese hospitals: the effects of implementing a pharmacy intravenous admixture service","volume":"59","author":"Zhang","year":"2016","journal-title":"Am. J. Ind. Med."}],"container-title":["International Journal of Hygiene and Environmental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438463923001554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438463923001554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T17:36:09Z","timestamp":1761413769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438463923001554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":55,"alternative-id":["S1438463923001554"],"URL":"https:\/\/doi.org\/10.1016\/j.ijheh.2023.114264","relation":{},"ISSN":["1438-4639"],"issn-type":[{"value":"1438-4639","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with internal contamination of nurses by antineoplastic drugs based on biomonitoring data from a previous study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Hygiene and Environmental Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijheh.2023.114264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114264"}}